Sartorius Stedim Biotech SA

Sartorius Stedim Biotech was founded in 1978 and is headquartered is Aubagne, France. This partner of the biopharma industry offers solutions to support cell cultivation, fermentation, filtration, purification, and fluid management. The company has offices, manufacturing plants, R&D and sales centres in more than 20 countries in Asia, Europe, and North America. Sartorius Stedim Biotech employs more than 5,600 employees around the world. In 2019, the company announced that it had signed an agreement to acquire parts of Danaher’s Life Science Portfolio for approximately $750 million in cash. The deal is expected to add technology for advancing and simplifying drug discovery procedures to Sartorius Stedim Biotech’s lab division’s portfolio. The company is listed on the stock exchange in Paris. Its financial results for the first nine months of fiscal 2019 include an 18.1% increase in sales revenue, reaching €1,076.7 million. Order intake for that time period reached €1,147.1 million. Invest in this instrument and stay updated on recent DIM.PA value changes.